trending Market Intelligence /marketintelligence/en/news-insights/trending/jXaTg3enNy1PY-ncySB3nQ2 content esgSubNav
In This List

ProPharma Group buys Southwood Research

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ProPharma Group buys Southwood Research

ProPharma Group, Inc., a portfolio company of private equity firm Linden Capital Partners LP, acquired U.K.-based Southwood Research, which provides pre-approval regulatory science services to pharmaceutical and biotech companies.

ProPharma, a compliance services company, is now able to provide end-to-end services within its global regulatory practice with the acquisitions of Southwood Research and U.S.-based Weinberg Group, which joined ProPharma in January. The group serves clients from the U.S., Canada, Europe, Japan and Australia.